| 19 |
Menger J, Lee ZY, Notz Q, et al. Administration of vitamin D and its metabolites in critically ill adult patients: an updated systematic review with meta-analysis of randomized controlled trials [J]. Crit Care, 2022, 26(1): 268.
|
| 20 |
Singer P, Blaser AR, Berger MM, et al. ESPEN guideline on clinical nutrition in the intensive care unit [J]. Clin Nutr, 2019, 38(1): 48-79.
|
| 21 |
Durup D, Jorgensen HL, Christensen J, et al. A reverse J-shaped association of all-cause mortality with serum 25-hydroxyvitamin D in general practice: the COPD study [J]. J Clin Endocrinol Metab, 2012, 97(8): 2644-2652.
|
| 22 |
Ralph R, Peter JV, Chrispal A, et al. Supraphysiological 25-hydroxy vitamin D3 level at admission is associated with illness severity and mortality in critically ill patients [J]. J Bone Miner Metab, 2015, 33(2): 239-243.
|
| 23 |
De La Hunty A, Wallace AM, Gibson S, et al. UK Food Standards Agency Workshop Consensus Report: the choice of method for measuring 25-hydroxyvitamin D to estimate vitamin D status for the UK National Diet and Nutrition Survey [J]. Br J Nutr, 2010, 104(4): 612-619.
|
| 24 |
Lai JK, Lucas RM, Banks E, et al. Variability in vitamin D assays impairs clinical assessment of vitamin D status [J]. Intern Med J, 2012, 42(1): 43-50.
|
| 25 |
Venkatesh B, Davidson B, Robinson K, et al. Do random estimations of vitamin D3 and parathyroid hormone reflect the 24-h profile in the critically ill? [J]. Intensive Care Med, 2012, 38(1): 177-179.
|
| 26 |
Ney J, Heyland DK, Amrein K, et al. The relevance of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D concentration for postoperative infections and postoperative organ dysfunctions in cardiac surgery patients: the eVIDenCe study [J]. Clin Nutr, 2019, 38(6): 2756-2762.
|
| 27 |
Martucci G, Tuzzolino F, Arcadipane A, et al. The effect of high-dose cholecalciferol on bioavailable vitamin D levels in critically ill patients: a post hoc analysis of the VITdAL-ICU trial [J]. Intensive Care Med, 2017, 43(11): 1732-1734.
|
| 28 |
Safadi FF, Thornton P, Magiera H, et al. Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein [J]. J Clin Invest, 1999, 103(2): 239-251.
|
| 29 |
Jassil NK, Sharma A, Bikle D, et al. Vitamin D binding protein and 25-hydroxyvitamin D levels: emerging clinical applications [J]. Endocr Pract, 2017, 23(5): 605-613.
|
| 30 |
Kempker JA, Tangpricha V, Ziegler TR, et al. Vitamin D in sepsis: from basic science to clinical impact [J]. Crit Care, 2012, 16(4): 316.
|
| 31 |
Madden K, Feldman HA, Chun RF, et al. Critically ill children have low vitamin D-binding protein, influencing bioavailability of vitamin D [J]. Ann Am Thorac Soc, 2015, 12(11): 1654-1661.
|
| 32 |
Suberviola B, Lavin BA, Jimenez AF, et al. Vitamin D binding protein, but not vitamin D or vitamin D-related peptides, is associated with septic shock mortality [J]. Enferm Infecc Microbiol Clin (Engl Ed), 2019, 37(4): 239-243.
|
| 33 |
De Pascale G, Quraishi SA. Vitamin D status in critically ill patients: the evidence is now bioavailable! [J]. Crit Care, 2014, 18(4): 449.
|
| 34 |
Berger MM, Shenkin A, Schweinlin A, et al. ESPEN micronutrient guideline [J]. Clin Nutr, 2022, 41(6): 1357-1424.
|
| 1 |
Giustina A, Bouillon R, Binkley N, et al. Controversies in Vitamin D: A Statement From the Third International Conference [J]. JBMR Plus, 2020, 4(12): e10417.
|
| 2 |
Mogire RM, Mutua A, Kimita W, et al. Prevalence of vitamin D deficiency in Africa: a systematic review and meta-analysis [J]. Lancet Glob Health, 2020, 8(1): e134-e142.
|
| 3 |
Hilger J, Friedel A, Herr R, et al. A systematic review of vitamin D status in populations worldwide [J]. Br J Nutr, 2014, 111(1): 23-45.
|
| 4 |
Amrein K, Zajic P, Schnedl C, et al. Vitamin D status and its association with season, hospital and sepsis mortality in critical illness [J]. Crit Care, 2014, 18(2): R47.
|
| 5 |
Rech MA, Hunsaker T, Rodriguez J. Deficiency in 25-hydroxyvitamin D and 30-day mortality in patients with severe sepsis and septic shock [J]. Am J Crit Care, 2014, 23(5): e72-9.
|
| 6 |
National Heart, Lung, and Blood Institute PETAL Clinical Trials Network; Ginde AA, Brower RG, Caterino JM, et al. Early high-dose vitamin D3 for critically ill, vitamin D-deficient patients [J]. N Engl J Med, 2019, 381(26): 2529-2540.
|
| 7 |
De Pascale G, Vallecoccia MS, Schiattarella A, et al. Clinical and microbiological outcome in septic patients with extremely low 25-hydroxyvitamin D levels at initiation of critical care [J]. Clin Microbiol Infect, 2016, 22(5): 456 e7- e13.
|
| 8 |
Moromizato T, Litonjua AA, Braun AB, et al. Association of low serum 25-hydroxyvitamin D levels and sepsis in the critically ill [J]. Crit Care Med, 2014, 42(1): 97-107.
|
| 9 |
Kvaran RB, Sigurdsson MI, Skarphedinsdottir SJ, et al. Severe vitamin D deficiency is common in critically ill patients at a high northern latitude [J]. Acta Anaesthesiol Scand, 2016, 60(9): 1289-1296.
|
| 10 |
Lucidarme O, Messai E, Mazzoni T, et al. Incidence and risk factors of vitamin D deficiency in critically ill patients: results from a prospective observational study [J]. Intensive Care Med, 2010, 36(9): 1609-1611.
|
| 11 |
Li Y, Ding S. Serum 25-Hydroxyvitamin D and the risk of mortality in adult patients with Sepsis: a meta-analysis [J]. BMC Infect Dis, 2020, 20(1): 189.
|
| 12 |
De Haan K, Groeneveld AB, De Geus HR, et al. Vitamin D deficiency as a risk factor for infection, sepsis and mortality in the critically ill: systematic review and meta-analysis [J]. Crit Care, 2014, 18(6): 660.
|
| 13 |
Braun AB, Litonjua AA, Moromizato T, et al. Association of low serum 25-hydroxyvitamin D levels and acute kidney injury in the critically ill [J]. Crit Care Med, 2012, 40(12): 3170-3179.
|
| 14 |
Vosoughi N, Kashefi P, Abbasi B, et al. The relationship between Vitamin D, clinical outcomes and mortality rate in ICU patients: A prospective observational study [J]. J Res Med Sci, 2016, 21: 75.
|
| 15 |
Amrein K, Schnedl C, Holl A, et al. Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinical trial [J]. JAMA, 2014, 312(15): 1520-1530.
|
| 16 |
Martucci G, Mcnally D, Parekh D, et al. Trying to identify who may benefit most from future vitamin D intervention trials: a post hoc analysis from the VITDAL-ICU study excluding the early deaths [J]. Crit Care, 2019, 23(1): 200.
|
| 17 |
Sistanizad M, Kouchek M, Miri M, et al. High dose vitamin D improves total serum antioxidant capacity and ICU outcome in critically ill patients - A randomized, double-blind clinical trial [J]. Eur J Integr Med, 2021, 42(101271): 101271.
|
| 18 |
Miri M, Kouchek M, Rahat Dahmardeh A, et al. Effect of high-dose vitamin D on duration of mechanical ventilation in ICU patients [J]. Iran J Pharm Res, 2019, 18(2): 1067-1072.
|
| 35 |
Amrein K, Sourij H, Wagner G, et al. Short-term effects of high-dose oral vitamin D3 in critically ill vitamin D deficient patients: a randomized, double-blind, placebo-controlled pilot study [J]. Crit Care, 2011, 15(2): R104.
|
| 36 |
Karsy M, Guan J, Eli I, et al. The effect of supplementation of vitamin D in neurocritical care patients: randomized clinical trial of hypovitaminosis D (RECTIFY) [J]. J Neurosurg, 2019, 13: 1-10.
|
| 37 |
Ingels C, Vanhorebeek I, Van Cromphaut S, et al. Effect of intravenous 25(OH)D supplementation on bone turnover and inflammation in prolonged critically ill patients [J]. Horm Metab Res, 2020, 52(3): 168-178.
|
| 38 |
Quraishi SA, De Pascale G, Needleman JS, et al. Effect of cholecalciferol supplementation on vitamin D status and cathelicidin levels in sepsis: a randomized, placebo-controlled trial [J]. Crit Care Med, 2015, 43(9): 1928-1937.
|
| 39 |
Han JE, Jones JL, Tangpricha V, et al. High dose vitamin D administration in ventilated intensive care unit patients: a pilot double blind randomized controlled trial [J]. J Clin Transl Endocrinol, 2016, 4: 59-65.
|
| 40 |
Hasanloei MAV, Rahimlou M, Eivazloo A, et al. Effect of oral versus intramuscular vitamin D replacement on oxidative stress and outcomes in traumatic mechanical ventilated patients admitted to intensive care unit [J]. Nutr Clin Pract, 2020, 35(3): 548-558.
|
| 41 |
Gupta N, Farooqui KJ, Batra CM, et al. Effect of oral versus intramuscular Vitamin D replacement in apparently healthy adults with Vitamin D deficiency [J]. Indian J Endocrinol Metab, 2017, 21(1): 131-136.
|
| 42 |
Quesada-Gomez JM, Bouillon R. Is calcifediol better than cholecalciferol for vitamin D supplementation? [J]. Osteoporos Int, 2018, 29(8): 1697-1711.
|
| 43 |
Leaf DE, Raed A, Donnino MW, et al. Randomized controlled trial of calcitriol in severe sepsis [J]. Am J Respir Crit Care Med, 2014, 190(5): 533-541.
|
| 44 |
Christopher KB. Vitamin D and critical illness outcomes [J]. Curr Opin Crit Care, 2016, 22(4): 332-338.
|
| 45 |
Bhattacharyya A, Subramaniam R, Baidya DK, et al. Effect of early administration of vitamin D on clinical outcome in critically ill sepsis patients: a randomized placebo-controlled trial [J]. Indian J Crit Care Med, 2021, 25(10): 1147-1154.
|
| 46 |
Szarpak L, Filipiak KJ, Gasecka A, et al. Vitamin D supplementation to treat SARS-CoV-2 positive patients. Evidence from meta-analysis [J]. Cardiol J, 2022, 29(2): 188-196.
|
| 47 |
Hosseini B, El Abd A, Ducharme FM. Effects of vitamin D supplementation on COVID-19 related outcomes: a systematic review and meta-analysis [J]. Nutrients, 2022, 14(10): 2134.
|